Assessing Continuous Glucose Monitors In Distinct Patient Populations

Wellness with a Wow

Assessing Continuous Glucose Monitors In Distinct Patient Populations

Three clinical trials are testing whether Continuous Glucose Monitors (CGMs) can outperform traditional blood glucose monitoring for patients with type 1 and 2 diabetes. The trials will assess CGM efficacy in distinct populations and provide a breadth of data to inform their use.

“These studies will hopefully help broaden CGM usage and indications currently approved by the FDA and U.S. insurance companies,” said Shichun Bao, M.D., Diabetes Technology Program Leader at Vanderbilt University Medical Center. Bao is principal investigator on two of the trials. Jordan Wright, M.D., an instructor at Vanderbilt, is principal investigator on the third, an inpatient trial on which Bao serves as faculty advisor.

READ MORE

 

We’re talking about a ‘New Year, New You‘ attitude about living with diabetes with musical inspiration from Aaliyah on Divabetic’s Diabetes Late Nite podcast.

Although Aaliyah died at the age of 22 and had a short music career due to her early passing, the singer’s music helped to redefine R&B, pop, and even hip-hop. And her legacy continues to live on. Her hard work ethic, creativity, and her sweet demeanor have inspired fans over the past two decades.

Diabetes Late Nite podcast guests include Patricia Addie-Gentle RN, CDE, Pendulum Therapeutics CEO and Co-Founder Colleen Cutcliffe, Ph. D., (the maker of Pendulum Glucose Control), Virginia Valentine, APRN, BC-ADM, CDE, FAADE, Dr. Darren Wayne from MealBetix and Yoga For Diabetes Author Rachel Zinman.

Throughout the podcast we will be featuring music from Aaliyah’s Age Ain’t Nothing But A Number album courtesy of SONY Music.

Tune in over 140 Diva TalkRadio podcasts available for free on i-tunes (search ‘Divabetic’).

Get the latest in diva news, diabetes headlines and inspiration by joining our Divabetic facebook page.

Leave a Reply